[go: up one dir, main page]

JP2001025462A - Physiological signal detecting device - Google Patents

Physiological signal detecting device

Info

Publication number
JP2001025462A
JP2001025462A JP11309594A JP30959499A JP2001025462A JP 2001025462 A JP2001025462 A JP 2001025462A JP 11309594 A JP11309594 A JP 11309594A JP 30959499 A JP30959499 A JP 30959499A JP 2001025462 A JP2001025462 A JP 2001025462A
Authority
JP
Japan
Prior art keywords
light
light emitting
emitting element
hemoglobin
wavelength characteristic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11309594A
Other languages
Japanese (ja)
Inventor
Rie Oosaki
理江 大崎
Shinji Nanba
晋治 難波
Sadasuke Kimura
禎祐 木村
Shigeo Numazawa
成男 沼澤
Satoru Kodama
悟 児玉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Denso Corp
Original Assignee
Denso Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denso Corp filed Critical Denso Corp
Priority to JP11309594A priority Critical patent/JP2001025462A/en
Publication of JP2001025462A publication Critical patent/JP2001025462A/en
Pending legal-status Critical Current

Links

Landscapes

  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

PROBLEM TO BE SOLVED: To improve the detecting probability of a pulse wave by improving the S/N ratio in a physiological signal detecting device equipped with a light emitting element and a photo-detecting element. SOLUTION: A pulse wave of a human body is detected by a photo-detecting element by detecting a reflected light or a scattered light from hemoglobin in the organism from among light emitted to the organism from a light emitting element 11. In this case, the light emitting element 11 is equipped with light emitting wavelength characteristics for a wavelength region wherein light absorption wavelength characteristics of hemoglobin and photo-detection sensitivity wavelength characteristics of a photo-detecting element 12 are combined. The light emitting element 11 is a light emitting diode wherein the light emitting wavelength characteristics can be converted, and its light emitting wavelength characteristics have light emitting wavelength peaks in approximately 440 nm and 550 nm.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、血液中のヘモグロ
ビンの吸光特性を利用して人体の脈波を測定する生体信
号検出装置に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a biological signal detecting apparatus for measuring a pulse wave of a human body by utilizing the absorption characteristics of hemoglobin in blood.

【0002】[0002]

【従来の技術】従来より、人体の脈波を測定する生体信
号検出装置として、指等の生体に光を照射する発光素子
と、発光素子から照射された光を受光する受光素子とを
備えたものが考えられている。
2. Description of the Related Art Conventionally, a biological signal detecting device for measuring a pulse wave of a human body includes a light emitting element for irradiating light to a living body such as a finger, and a light receiving element for receiving light emitted from the light emitting element. Things are considered.

【0003】この生体信号検出装置では、発光素子から
の照射光が生体内の毛細動脈に当たり、一部は血液中の
ヘモグロビンに吸収され、一部は反射または散乱されて
反射光または散乱光となり、この反射光または散乱光を
受光素子で受光する。このとき、血管中を流れる血液量
が増えるとヘモグロビンで吸収される照射光の割合が増
えて受光素子で受光される反射光または散乱光が弱くな
り、逆に血液量が減ると照射光のうちヘモグロビンで吸
収される割合が減って反射光または散乱光が強くなる。
従って、受光素子によって検出される反射光または散乱
光の強度変化を求めることによって、脈波の定量的な数
値データが検出できる。
In this biological signal detecting device, irradiation light from a light emitting element hits a capillary in a living body, a part of which is absorbed by hemoglobin in blood, and a part is reflected or scattered to be reflected light or scattered light. The reflected light or the scattered light is received by the light receiving element. At this time, if the amount of blood flowing through the blood vessels increases, the proportion of irradiation light absorbed by hemoglobin increases, and the reflected light or scattered light received by the light receiving element becomes weaker. The proportion absorbed by hemoglobin is reduced, and reflected light or scattered light is increased.
Therefore, quantitative numerical data of the pulse wave can be detected by calculating the intensity change of the reflected light or the scattered light detected by the light receiving element.

【0004】[0004]

【発明が解決しようとする課題】このような生体信号検
出装置では、従来、発光素子から照射される光として赤
色光(例えば波長700nm)が用いられていた。しか
しながら赤色光では、ヘモグロビンの吸光度が小さく、
また、皮膚表面での反射または散乱が大きいため、結果
としてS/N比が悪く、脈波の検出確率が小さいという
問題があった。
In such a biological signal detecting device, red light (for example, a wavelength of 700 nm) is conventionally used as light emitted from a light emitting element. However, with red light, the absorbance of hemoglobin is small,
In addition, since reflection or scattering at the skin surface is large, there is a problem that the S / N ratio is poor and the detection probability of a pulse wave is small.

【0005】また、特開平8−80288号、特開平8
−266493号の各公報において、300〜700n
mの波長範囲に単一の発光波長ピークをもつ発光素子を
備えた生体信号検出装置が記載されている。しかしなが
ら、この装置ではヘモグロビンの具体的な吸光波長特
性、受光素子の感度波長特性が考慮されておらず、な
お、S/N比が低い。
[0005] Japanese Patent Application Laid-Open No. 8-80288,
-266493, 300-700n
A biological signal detection device including a light emitting element having a single emission wavelength peak in a wavelength range of m is described. However, this device does not take into account the specific absorption wavelength characteristics of hemoglobin and the sensitivity wavelength characteristics of the light receiving element, and the S / N ratio is low.

【0006】本発明は、上記点に鑑み、発光素子と受光
素子を備えた生体信号検出装置において、S/N比を向
上させて脈波の検出確率を向上させることを目的とす
る。
In view of the above, it is an object of the present invention to improve the S / N ratio and improve the probability of detecting a pulse wave in a biological signal detecting device provided with a light emitting element and a light receiving element.

【0007】[0007]

【課題を解決するための手段】本発明は、上記目的を達
成するために、請求項1に記載の発明では、発光素子
(11)は、ヘモグロビンの吸光波長特性と、受光素子
(12)の受光感度波長特性とを掛け合わせた吸光感度
波長特性のピーク波長領域近辺にピークを有する発光波
長特性を備えることを特徴としている。
In order to achieve the above object, according to the first aspect of the present invention, the light emitting element (11) includes a light-absorbing wavelength characteristic of hemoglobin and a light-receiving element (12). It is characterized by having an emission wavelength characteristic having a peak near a peak wavelength region of the absorption sensitivity wavelength characteristic multiplied by the light reception sensitivity wavelength characteristic.

【0008】発光素子(11)の照射光がヘモグロビン
(31)の吸光度が大きい波長領域の光であるほど、ヘ
モグロビン(31)に吸収されずに受光素子に検出され
る反射光または散乱光の強度は毛細動脈内を流れる血液
量の変化に感度よく反応する。また、発光素子(11)
からの照射光が受光素子(12)の受光感度が高い波長
領域の光であるほど、受光素子(12)で反射光または
散乱光を感度よく検出できる。
[0008] As the irradiation light of the light emitting element (11) is light in a wavelength region where the absorbance of the hemoglobin (31) is large, the intensity of reflected light or scattered light detected by the light receiving element without being absorbed by the hemoglobin (31). Responds sensitively to changes in the amount of blood flowing through the capillaries. Also, the light emitting element (11)
As the irradiation light from the light source is a light in a wavelength region where the light receiving sensitivity of the light receiving element (12) is high, the reflected light or the scattered light can be detected with higher sensitivity by the light receiving element (12).

【0009】従って、このように、発光素子(11)の
発光波長特性を、ヘモグロビンの吸光波長特性と、受光
素子(12)の受光感度波長特性とを掛け合わせた吸光
感度波長特性のピーク波長領域近辺にピークを有するも
のとすることにより、脈波を検出する際にS/N比が向
上し、脈波の検出確率を向上させることができる。
Accordingly, the emission wavelength characteristic of the light emitting element (11) is obtained by multiplying the emission wavelength characteristic of hemoglobin by the light absorption wavelength characteristic of the light receiving element (12). By having a peak in the vicinity, the S / N ratio can be improved when detecting a pulse wave, and the detection probability of a pulse wave can be improved.

【0010】なお、本明細書中でいうヘモグロビンと
は、毛細動脈中を流れる酸素と結合した酸素化ヘモグロ
ビンをいう。
The term "hemoglobin" as used herein refers to oxygenated hemoglobin combined with oxygen flowing in a capillary artery.

【0011】また、上記発光素子(11)は、具体的に
は、請求項2に記載の発明のように、発光波長特性を変
換可能な発光ダイオードとすることができ、さらに、上
記発光素子(11)の発光波長特性は、請求項3に記載
の発明のように、440nm付近または550nm付近
に発光波長ピークを有するものとすることができる。
The light-emitting element (11) can be, specifically, a light-emitting diode whose emission wavelength characteristic can be converted, as described in the second aspect of the present invention. The emission wavelength characteristic of 11) can have an emission wavelength peak around 440 nm or around 550 nm as in the invention described in claim 3.

【0012】なお、上記各手段の括弧内の符号は、後述
する実施形態に記載の具体的手段との対応関係を示す一
例である。
Incidentally, the reference numerals in parentheses of the above means are examples showing the correspondence with specific means described in the embodiments described later.

【0013】[0013]

【発明の実施の形態】以下、本発明を適用した生体信号
検出装置を図に基づいて説明する。
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS A biological signal detecting apparatus to which the present invention is applied will be described below with reference to the drawings.

【0014】この生体信号検出装置100は、生体信号
である脈波の検出および継続モニタを行うことにより、
例えば病院内の被介護者の容体の検出のような、医学診
断、健康管理、個人認識等に利用される。
The biological signal detecting apparatus 100 detects a pulse wave as a biological signal and continuously monitors the pulse wave,
For example, it is used for medical diagnosis, health management, personal recognition and the like, such as detection of the condition of a cared person in a hospital.

【0015】以下、図1、図2に基づき生体信号検出装
置100の構成について説明する。図1は本発明を適用
した指輪型の生体信号検出装置100を示し、図2は生
体信号検出装置100に備えられた脈波検出部1の拡大
断面を示している。
Hereinafter, the configuration of the biological signal detecting device 100 will be described with reference to FIGS. FIG. 1 shows a ring-type biological signal detecting device 100 to which the present invention is applied, and FIG. 2 shows an enlarged cross section of a pulse wave detecting section 1 provided in the biological signal detecting device 100.

【0016】図1に示すように、生体信号検出装置10
0は、脈波を検出する脈波検出部1、この脈波検出部1
を指に固定するための円環状のリング部2、および脈波
検出部1で検出した信号の処理等を行う信号処理部(図
示せず)とから構成されている。
As shown in FIG. 1, the biological signal detecting device 10
0 is a pulse wave detecting unit 1 for detecting a pulse wave,
And a signal processing unit (not shown) for processing a signal detected by the pulse wave detecting unit 1 and the like.

【0017】脈波検出部1は、ケース10の内部に発光
ダイオード(LED)からなる発光素子11とフォトダ
イオード(PD)からなる受光素子12とが備えられて
おり、これら発光素子11と受光素子12はケース10
内で隣接配置されている。発光素子11から指(生体)
30に向けて光が照射され、この照射光のうち血液中の
ヘモグロビン31によって吸収されなかった光を、反射
光または散乱光として受光素子12で受光することによ
って脈波を検出することができる。
The pulse wave detector 1 includes a light emitting element 11 composed of a light emitting diode (LED) and a light receiving element 12 composed of a photodiode (PD) inside a case 10. 12 is case 10
Are located adjacent to each other. Finger (living body) from light emitting element 11
The light is irradiated toward the light 30, and the light not absorbed by the hemoglobin 31 in the blood is received by the light receiving element 12 as reflected light or scattered light, whereby a pulse wave can be detected.

【0018】また、ケース10の図中上部(指に接触す
る部分)には、光が透過するアクリル板等からなる窓部
13が設けられている。
A window 13 made of an acrylic plate or the like through which light is transmitted is provided in an upper portion of the case 10 (a portion in contact with a finger) in the drawing.

【0019】図1に示す生体信号検出装置100は、紙
面上方向が指30の背側に、紙面下方向が指30の腹側
に位置するように、すなわち、脈波検出部1が指30の
腹側に位置するように配置される。このように、発光素
子11と受光素子12を指30の背側よりも血管が多い
腹側に配置することにより、効果的に脈波の検出を行う
ことができる。
The biological signal detecting apparatus 100 shown in FIG. 1 is arranged such that the upper side of the page is located on the back side of the finger 30 and the lower side of the page is located on the ventral side of the finger 30, that is, the pulse wave detecting section 1 It is arranged so as to be located on the ventral side. In this way, by arranging the light emitting element 11 and the light receiving element 12 on the abdominal side having more blood vessels than the back side of the finger 30, pulse wave can be effectively detected.

【0020】本実施形態では、発光素子11としてIn
GaN系(インジウム−ガリウム−窒素系)の青色LE
Dであって、発光した光をアクリル板等に塗布した蛍光
塗料を通過させることによって光の波長を変換できる波
長変換LEDを用いている。また、受光素子12として
GaAsP系(ガリウム−砒素−リン系)のPDを用い
ている。
In this embodiment, the light emitting element 11 is In
GaN-based (indium-gallium-nitrogen-based) blue LE
D is a wavelength conversion LED that can convert the wavelength of light by passing emitted light through a fluorescent paint applied to an acrylic plate or the like. Further, a GaAsP (gallium-arsenic-phosphorus) PD is used as the light receiving element 12.

【0021】ところで、生体信号検出装置100で人体
の脈波を検出する際に、発光素子11から生体に向けて
照射する光のうち生体内で反射または散乱する光が検出
すべき信号であり、これに対して発光素子11の照射光
のうち皮膚表面、生体内の組織あるいは窓部13等で反
射または散乱する光がノイズとなる。
By the way, when detecting a pulse wave of a human body by the biological signal detecting device 100, light reflected or scattered in the living body among the light irradiated from the light emitting element 11 toward the living body is a signal to be detected. On the other hand, of the irradiation light of the light emitting element 11, light reflected or scattered on the skin surface, tissue in the living body, the window 13, or the like becomes noise.

【0022】そして、発光素子11の照射光がヘモグロ
ビン31の吸光度が大きい波長領域の光であるほど、ヘ
モグロビン31によって吸収されなかった反射光または
散乱光の強度は毛細動脈内を流れる血液量の変化に感度
よく反応する。このため、発光素子11からの照射光の
波長特性は、ヘモグロビン31の吸光波長特性とできる
だけ一致している方がS/N比(脈波の検出率)が向上
する。
The intensity of the reflected or scattered light not absorbed by the hemoglobin 31 changes with the change in the amount of blood flowing through the capillary artery as the irradiation light of the light emitting element 11 is in a wavelength region where the absorbance of the hemoglobin 31 is large. Reacts with high sensitivity. For this reason, the S / N ratio (pulse wave detection rate) improves when the wavelength characteristic of the irradiation light from the light emitting element 11 matches the absorption wavelength characteristic of hemoglobin 31 as much as possible.

【0023】さらに、発光素子11からの照射光が受光
素子12の受光感度が高い波長領域の光であるほど、受
光素子12で反射光または散乱光を感度よく検出でき
る。このため、発光素子11からの照射光の波長特性
は、受光素子12の受光感度波長特性とできるだけ一致
している方がS/N比が向上する。
Further, as the irradiation light from the light emitting element 11 is in the wavelength region where the light receiving sensitivity of the light receiving element 12 is high, the light receiving element 12 can detect reflected light or scattered light with higher sensitivity. Therefore, the S / N ratio is improved when the wavelength characteristic of the irradiation light from the light emitting element 11 matches the light receiving sensitivity wavelength characteristic of the light receiving element 12 as much as possible.

【0024】したがって、上記のヘモグロビン31の吸
光波長特性と受光素子12の受光感度波長特性はできる
だけ近似している方が望ましい。
Therefore, it is desirable that the absorption wavelength characteristic of the hemoglobin 31 and the light reception sensitivity wavelength characteristic of the light receiving element 12 be as close as possible.

【0025】しかしながら、これらの波長特性は一致し
ておらず、具体的には、ヘモグロビンは図3に示すよう
に、420nm付近に大きなピークをもつ吸光波長特性
を有しており、受光素子12は図4に示すように、90
0nm付近にピークをもつ受光感度波長特性を有してい
る。
However, these wavelength characteristics do not match. Specifically, as shown in FIG. 3, hemoglobin has an absorption wavelength characteristic having a large peak near 420 nm, and the light-receiving element 12 As shown in FIG.
It has a light receiving sensitivity wavelength characteristic having a peak near 0 nm.

【0026】そこで、本実施形態における発光素子11
は、図3に示すヘモグロビンの吸光波長特性と図4に示
す受光素子11の受光感度波長特性とを掛け合わせた
(合成した)吸光感度波長特性のピーク波長領域近辺に
ピークを有する発光波長特性を有するものを使用する。
具体的には、本実施形態の発光素子12は、図5に示す
ように、440nm付近に第1のピーク、550nm付
近に第1のピークより大きい第2のピークという2つの
発光波長ピークを持つ発光波長特性を有している。
Therefore, the light emitting element 11 in the present embodiment
Is the emission wavelength characteristic having a peak near the peak wavelength region of the absorption sensitivity wavelength characteristic obtained by multiplying (synthesizing) the absorption wavelength characteristic of hemoglobin shown in FIG. 3 and the sensitivity wavelength characteristic of the light receiving element 11 shown in FIG. Use what you have.
Specifically, as shown in FIG. 5, the light emitting element 12 of the present embodiment has two emission wavelength peaks, namely, a first peak around 440 nm and a second peak larger than the first peak around 550 nm. It has emission wavelength characteristics.

【0027】図5に示す形の発光波長特性を得るため
に、本実施形態では上記のように発光素子11に波長変
換LEDを用いている。具体的には、InGaN系の青
色LEDで発光した光の波長特性は440nm付近に単
一のピークを有するものであるが、この光を蛍光塗料に
通過させることにより、新たに550nm付近にピーク
を有する光が生成され、これらが合成されることによ
り、図5に示す発光波長特性の光を生成することができ
る。
In this embodiment, a wavelength conversion LED is used for the light emitting element 11 as described above in order to obtain the emission wavelength characteristic shown in FIG. Specifically, the wavelength characteristic of the light emitted from the InGaN-based blue LED has a single peak around 440 nm. By passing this light through the fluorescent paint, a new peak is formed around 550 nm. The light having the emission wavelength characteristics shown in FIG. 5 can be generated by generating the light having the light and combining them.

【0028】図6は生体(皮膚)表面での光の散乱また
は反射特性を示しており、図5に示す発光素子11の発
光波長特性であれば皮膚表面での反射光または散乱光が
小さいため、さらに良好なS/N比を得ることができ
る。
FIG. 6 shows the scattering or reflection characteristics of light on the surface of the living body (skin). If the emission wavelength characteristics of the light emitting element 11 shown in FIG. 5 are used, the light reflected or scattered on the skin surface is small. And an even better S / N ratio can be obtained.

【0029】なお、リング部2の一部には、発光素子1
1や受光素子12と信号処理部(図示せず)との電気的
接続を行うための電気配線(図示せず)が内蔵されてお
り、この電気配線にて発光素子11や受光素子12への
通電が行えるようになっている。
It should be noted that the light emitting element 1
1 and the light receiving element 12 and an electric wiring (not shown) for electrically connecting the signal processing unit (not shown) to the light emitting element 11 and the light receiving element 12 with this electric wiring. Electricity can be supplied.

【0030】次に、図1に示す生体信号検出装置100
の作動について説明する。
Next, the biological signal detecting device 100 shown in FIG.
The operation of will be described.

【0031】上記通電が行われると、発光素子11が生
体(指)に向けて光を照射する。この照射光の一部は皮
膚表面で反射または散乱する。そして、生体内において
照射光の一部が毛細動脈を流れる血液中のヘモグロビン
31に吸収され、一部が生体内で反射または散乱され
る。そして、この反射光または散乱光を受光素子12が
受光し、受光素子12から反射光または散乱光の強度に
相応した検出信号が生体信号として図示しない信号処理
部に送られる。
When the energization is performed, the light emitting element 11 emits light toward the living body (finger). Some of this illuminating light is reflected or scattered on the skin surface. Then, part of the irradiation light in the living body is absorbed by hemoglobin 31 in the blood flowing through the capillary artery, and part is reflected or scattered in the living body. The reflected light or the scattered light is received by the light receiving element 12, and a detection signal corresponding to the intensity of the reflected light or the scattered light is sent from the light receiving element 12 to a signal processing unit (not shown) as a biological signal.

【0032】受光素子12における受光量の変化は、毛
細動脈中のヘモグロビン31の量の変化に対応してい
る。すなわち、ヘモグロビン31が増加すれば照射光の
うちヘモグロビン31で吸収される割合が増加して反射
光または散乱光は弱くなり、逆にヘモグロビン31が減
少すれば照射光のうちヘモグロビン31で吸収される割
合が減少して反射光または散乱光は強くなる。
The change in the amount of light received by the light receiving element 12 corresponds to the change in the amount of hemoglobin 31 in the capillary arteries. That is, if the hemoglobin 31 increases, the proportion of the irradiation light absorbed by the hemoglobin 31 increases, and the reflected light or the scattered light weakens. Conversely, if the hemoglobin 31 decreases, the absorption light is absorbed by the hemoglobin 31 of the irradiation light. The proportion decreases and the reflected or scattered light becomes stronger.

【0033】毛細動脈中のヘモグロビン31の量は、血
液の脈動により波動的に変化するので、ヘモグロビン3
1に吸収される光も波動的に変化し、これに連動してヘ
モグロビン31に吸収されずに生体内で反射または散乱
する光の強度も波動的に変化する。そこで、反射光また
は散乱光の強度変化を受光素子12で継続的に測定する
ことにより、毛細動脈中を流れる血液量の変化、すなわ
ち脈波を測定することができる。
The amount of hemoglobin 31 in the capillary arteries changes in a wave-like manner due to the pulsation of blood.
The light absorbed by 1 also changes in a wavelike manner, and the intensity of light reflected or scattered in the living body without being absorbed by the hemoglobin 31 also changes in conjunction with this. Therefore, by continuously measuring the intensity change of the reflected light or the scattered light by the light receiving element 12, the change in the amount of blood flowing in the capillary artery, that is, the pulse wave can be measured.

【0034】受光素子12の検出信号に基づいて生体信
号検出装置100は以下の処理を実行する。この処理に
ついてのブロック図を図7に示し、この図に基づいて生
体信号検出装置が実行する処理について説明する。
The biological signal detection device 100 executes the following processing based on the detection signal of the light receiving element 12. FIG. 7 shows a block diagram of this processing, and the processing executed by the biological signal detection device will be described based on this drawing.

【0035】上述したように、発光素子11及び受光素
子12への通電が行われると、信号処理部に脈波の検出
信号が送られる。この検出信号は増幅回路20で増幅さ
れたのち、バンドパスフィルタ回路21でノイズ除去さ
れ、A/D変換回路22にてデジタル信号に変換され
る。
As described above, when the light emitting element 11 and the light receiving element 12 are energized, a pulse wave detection signal is sent to the signal processing unit. This detection signal is amplified by an amplifier circuit 20, then noise is removed by a band-pass filter circuit 21, and is converted into a digital signal by an A / D conversion circuit 22.

【0036】このデジタル信号を図示しない信号処理部
内に内蔵されたCPU23がデータ処理する。このデー
タ処理では、例えばデジタル信号をシリアル化したの
ち、シリアル化されたデジタル信号に付加信号(ヘッダ
ー信号、ID信号、パリティ信号等)を付加する処理を
行う。そして、送信装置24にて処理されたデータの送
信を行う。
The digital signal is subjected to data processing by a CPU 23 incorporated in a signal processing unit (not shown). In this data processing, for example, after a digital signal is serialized, a process of adding an additional signal (a header signal, an ID signal, a parity signal, or the like) to the serialized digital signal is performed. Then, the data processed by the transmission device 24 is transmitted.

【0037】この送信されたデータは別置きの受信装置
(図示せず)で受信され、受信された脈波のデータに基
づいて被介護者の容体の判断等を行う。
The transmitted data is received by a separate receiving device (not shown), and the condition of the care receiver is determined based on the received pulse wave data.

【0038】次に、本発明者らが本実施形態の生体信号
検出装置100によって脈波を測定した結果を図8に基
づいて説明する。
Next, the results of measurement of a pulse wave by the present inventors using the biological signal detection device 100 of the present embodiment will be described with reference to FIG.

【0039】図8は、種々の発光波長特性を有する発光
素子を用いた場合A、B、C、Dにおける検出した脈波
の強度を示している。具体的には、Aは本実施形態の発
光波長特性を有する発光素子、Bは520nmに単一の
ピークを持つ発光波長特性を有する発光素子、Cは46
5nmに単一のピークを持つ発光波長特性を有する発光
素子、Dは655nmに単一のピークを持つ発光波長特
性を有する発光素子を使用した場合を示している。
FIG. 8 shows detected pulse wave intensities in A, B, C, and D when light emitting elements having various emission wavelength characteristics are used. Specifically, A is a light emitting element having the emission wavelength characteristic of the present embodiment, B is a light emitting element having an emission wavelength characteristic having a single peak at 520 nm, and C is 46.
D indicates the case where a light emitting element having an emission wavelength characteristic having a single peak at 5 nm, and D indicates the case of using a light emitting element having an emission wavelength characteristic having a single peak at 655 nm.

【0040】図8から理解できるように、本実施形態の
ように、ヘモグロビンの吸光特性と受光素子12の感度
特性を掛け合わせた吸光感度波長特性のピーク波長領域
近辺にピークを有する発光波長特性(図5)を有する発
光素子11を用いることにより、S/N比が良好で脈波
の検出感度が高い生体信号検出装置を提供することがで
きる。
As can be understood from FIG. 8, as in the present embodiment, the emission wavelength characteristic having a peak in the vicinity of the peak wavelength region of the absorption sensitivity wavelength characteristic obtained by multiplying the absorption characteristic of hemoglobin and the sensitivity characteristic of the light receiving element 12 is shown. By using the light emitting element 11 having the configuration shown in FIG. 5), it is possible to provide a biological signal detecting device having a good S / N ratio and high pulse wave detection sensitivity.

【0041】なお、上述した実施形態では、440nm
付近に第1のピーク、550nm付近に第1のピークよ
り大きな第2のピークを持つ発光波長特性を備えた発光
素子について説明したが、どちらか一方の波長領域にピ
ークを有する発光素子を用いてもよい。ただし、ヘモグ
ロビンの吸光波長特性のピークである420nm付近で
は、受光素子の感度がかなり低下するので、発光素子と
しては550nm付近にピーク波長を有することが望ま
しい。具体的には、発光素子が520nm〜580nm
の波長領域に発光波長のピークを有することにより、実
用上、S/N比を良好なレベルに保つことができる。
In the embodiment described above, 440 nm
A light emitting element having a light emission wavelength characteristic having a first peak near 550 nm and a second peak larger than the first peak near 550 nm has been described, but a light emitting element having a peak in either one of the wavelength regions is used. Is also good. However, since the sensitivity of the light receiving element is considerably reduced around 420 nm, which is the peak of the absorption wavelength characteristic of hemoglobin, it is desirable that the light emitting element has a peak wavelength around 550 nm. Specifically, the light emitting element has a size of 520 nm to 580 nm.
, The S / N ratio can be kept at a favorable level in practical use.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本実施形態の生体信号検出装置を指に装着した
状態を示す断面図である。
FIG. 1 is a cross-sectional view showing a state in which a biological signal detection device according to an embodiment is mounted on a finger.

【図2】図1の生体信号検出装置の脈波検出部の拡大断
面図である。
FIG. 2 is an enlarged cross-sectional view of a pulse wave detection unit of the biological signal detection device of FIG.

【図3】ヘモグロビンの吸光波長特性を示す特性図であ
る。
FIG. 3 is a characteristic diagram showing absorption wavelength characteristics of hemoglobin.

【図4】受光素子の受光感度波長特性を示す特性図であ
る。
FIG. 4 is a characteristic diagram illustrating light-receiving sensitivity wavelength characteristics of a light-receiving element.

【図5】ヘモグロビンの吸光波長特性と受光素子の受光
感度波長特性を掛け合わせた吸光感度波長特性を示す特
性図である。
FIG. 5 is a characteristic diagram showing an absorption wavelength characteristic obtained by multiplying an absorption wavelength characteristic of hemoglobin and a light reception wavelength characteristic of a light receiving element.

【図6】生体(皮膚)表面における反射散乱特性を示す
特性図である。
FIG. 6 is a characteristic diagram showing reflection scattering characteristics on the surface of a living body (skin).

【図7】生体信号検出装置が実行する処理のブロック図
である。
FIG. 7 is a block diagram of a process executed by the biological signal detection device.

【図8】種々の波長特性を有する発光素子を用いた場合
の脈波の強度を示す特性図である。
FIG. 8 is a characteristic diagram showing pulse wave intensity when light emitting elements having various wavelength characteristics are used.

【符号の説明】[Explanation of symbols]

1…脈波検出部、2…リング部、10…ケース、11…
発光素子、12…受光素子、30…生体(指)、31…
ヘモグロビン、100…生体信号検出装置。
DESCRIPTION OF SYMBOLS 1 ... Pulse wave detection part, 2 ... Ring part, 10 ... Case, 11 ...
Light emitting element, 12 light receiving element, 30 living body (finger), 31
Hemoglobin, 100: biological signal detection device.

フロントページの続き (72)発明者 木村 禎祐 愛知県刈谷市昭和町1丁目1番地 株式会 社デンソー内 (72)発明者 沼澤 成男 愛知県刈谷市昭和町1丁目1番地 株式会 社デンソー内 (72)発明者 児玉 悟 愛知県刈谷市昭和町1丁目1番地 株式会 社デンソー内 Fターム(参考) 4C017 AA09 AB03 AC28 FF15 4C038 KL07 KM01 VB13 VC01 Continuing from the front page (72) Inventor Teisuke Kimura 1-1-1, Showa-cho, Kariya-shi, Aichi Pref. 72) Inventor Satoru Kodama 1-1-1 Showa-cho, Kariya-shi, Aichi F-term in DENSO Corporation 4C017 AA09 AB03 AC28 FF15 4C038 KL07 KM01 VB13 VC01

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 生体の一部に向けて光を照射する発光素
子(11)と、 前記発光素子(11)から照射された光を受光する受光
素子(12)とを備え、 前記発光素子(11)から照射された光の一部が前記生
体内のヘモグロビンによって吸収されつつ、吸収されな
かった光を反射光または散乱光として受光素子で検出す
ることで、人体の脈波を検出する生体信号検出装置であ
って、 前記発光素子(11)は、前記ヘモグロビンの吸光波長
特性と、前記受光素子(12)の受光感度波長特性とを
掛け合わせた吸光感度波長特性のピーク波長領域近辺に
ピークを有する発光波長特性を備えることを特徴とする
生体信号検出装置。
1. A light-emitting element (11) for irradiating light to a part of a living body, and a light-receiving element (12) for receiving light emitted from the light-emitting element (11), A biological signal for detecting a pulse wave of a human body by detecting, with a light receiving element, a part of the light irradiated from step 11) as reflected light or scattered light while absorbing part of the light absorbed by hemoglobin in the living body. The detection device, wherein the light emitting element (11) has a peak near a peak wavelength region of an absorption sensitivity wavelength characteristic obtained by multiplying an absorption wavelength characteristic of the hemoglobin and a reception sensitivity wavelength characteristic of the light receiving element (12). A biological signal detection device having emission wavelength characteristics.
【請求項2】 前記発光素子(11)は、発光波長特性
を変換可能な発光ダイオードであることを特徴とする請
求項1の記載の生体信号検出装置。
2. The biological signal detecting device according to claim 1, wherein the light emitting element is a light emitting diode capable of converting an emission wavelength characteristic.
【請求項3】 前記発光素子(11)は、発光体の上に
蛍光体を設けて波長変換することにより、少なくとも4
40nm付近又は550nm付近に発光波長ピークを有
する発光波長特性を備えることを特徴とする請求項1ま
たは2に記載の生体信号検出装置。
3. The light-emitting element (11) is provided with a phosphor on a light-emitting body and wavelength-converted to at least four light-emitting elements.
The biological signal detection device according to claim 1, further comprising an emission wavelength characteristic having an emission wavelength peak around 40 nm or around 550 nm.
JP11309594A 1999-05-10 1999-10-29 Physiological signal detecting device Pending JP2001025462A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11309594A JP2001025462A (en) 1999-05-10 1999-10-29 Physiological signal detecting device

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11-129092 1999-05-10
JP12909299 1999-05-10
JP11309594A JP2001025462A (en) 1999-05-10 1999-10-29 Physiological signal detecting device

Publications (1)

Publication Number Publication Date
JP2001025462A true JP2001025462A (en) 2001-01-30

Family

ID=26464605

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11309594A Pending JP2001025462A (en) 1999-05-10 1999-10-29 Physiological signal detecting device

Country Status (1)

Country Link
JP (1) JP2001025462A (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012518515A (en) * 2009-02-25 2012-08-16 ヴァレンセル,インコーポレイテッド Light guide device and monitor device incorporating the same
US8655426B2 (en) 2008-04-25 2014-02-18 Denso Corporation Device for measuring concentration of constituent in blood and measuring method
US8788002B2 (en) 2009-02-25 2014-07-22 Valencell, Inc. Light-guiding devices and monitoring devices incorporating same
US9044180B2 (en) 2007-10-25 2015-06-02 Valencell, Inc. Noninvasive physiological analysis using excitation-sensor modules and related devices and methods
US9427191B2 (en) 2011-07-25 2016-08-30 Valencell, Inc. Apparatus and methods for estimating time-state physiological parameters
WO2016150749A1 (en) 2015-03-23 2016-09-29 Koninklijke Philips N.V. Optical vital signs sensor
US9538921B2 (en) 2014-07-30 2017-01-10 Valencell, Inc. Physiological monitoring devices with adjustable signal analysis and interrogation power and monitoring methods using same
US9750462B2 (en) 2009-02-25 2017-09-05 Valencell, Inc. Monitoring apparatus and methods for measuring physiological and/or environmental conditions
US9794653B2 (en) 2014-09-27 2017-10-17 Valencell, Inc. Methods and apparatus for improving signal quality in wearable biometric monitoring devices
US9801552B2 (en) 2011-08-02 2017-10-31 Valencell, Inc. Systems and methods for variable filter adjustment by heart rate metric feedback
US10015582B2 (en) 2014-08-06 2018-07-03 Valencell, Inc. Earbud monitoring devices
US10076253B2 (en) 2013-01-28 2018-09-18 Valencell, Inc. Physiological monitoring devices having sensing elements decoupled from body motion
US10258243B2 (en) 2006-12-19 2019-04-16 Valencell, Inc. Apparatus, systems, and methods for measuring environmental exposure and physiological response thereto
US10413197B2 (en) 2006-12-19 2019-09-17 Valencell, Inc. Apparatus, systems and methods for obtaining cleaner physiological information signals
US10610158B2 (en) 2015-10-23 2020-04-07 Valencell, Inc. Physiological monitoring devices and methods that identify subject activity type
US10827979B2 (en) 2011-01-27 2020-11-10 Valencell, Inc. Wearable monitoring device
US10945618B2 (en) 2015-10-23 2021-03-16 Valencell, Inc. Physiological monitoring devices and methods for noise reduction in physiological signals based on subject activity type
US10966662B2 (en) 2016-07-08 2021-04-06 Valencell, Inc. Motion-dependent averaging for physiological metric estimating systems and methods

Cited By (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11109767B2 (en) 2006-12-19 2021-09-07 Valencell, Inc. Apparatus, systems and methods for obtaining cleaner physiological information signals
US11272849B2 (en) 2006-12-19 2022-03-15 Valencell, Inc. Wearable apparatus
US10987005B2 (en) 2006-12-19 2021-04-27 Valencell, Inc. Systems and methods for presenting personal health information
US11350831B2 (en) 2006-12-19 2022-06-07 Valencell, Inc. Physiological monitoring apparatus
US10716481B2 (en) 2006-12-19 2020-07-21 Valencell, Inc. Apparatus, systems and methods for monitoring and evaluating cardiopulmonary functioning
US11083378B2 (en) 2006-12-19 2021-08-10 Valencell, Inc. Wearable apparatus having integrated physiological and/or environmental sensors
US10595730B2 (en) 2006-12-19 2020-03-24 Valencell, Inc. Physiological monitoring methods
US11272848B2 (en) 2006-12-19 2022-03-15 Valencell, Inc. Wearable apparatus for multiple types of physiological and/or environmental monitoring
US10413197B2 (en) 2006-12-19 2019-09-17 Valencell, Inc. Apparatus, systems and methods for obtaining cleaner physiological information signals
US11412938B2 (en) 2006-12-19 2022-08-16 Valencell, Inc. Physiological monitoring apparatus and networks
US10258243B2 (en) 2006-12-19 2019-04-16 Valencell, Inc. Apparatus, systems, and methods for measuring environmental exposure and physiological response thereto
US11399724B2 (en) 2006-12-19 2022-08-02 Valencell, Inc. Earpiece monitor
US11295856B2 (en) 2006-12-19 2022-04-05 Valencell, Inc. Apparatus, systems, and methods for measuring environmental exposure and physiological response thereto
US11324407B2 (en) 2006-12-19 2022-05-10 Valencell, Inc. Methods and apparatus for physiological and environmental monitoring with optical and footstep sensors
US11395595B2 (en) 2006-12-19 2022-07-26 Valencell, Inc. Apparatus, systems and methods for monitoring and evaluating cardiopulmonary functioning
US11000190B2 (en) 2006-12-19 2021-05-11 Valencell, Inc. Apparatus, systems and methods for obtaining cleaner physiological information signals
US9808204B2 (en) 2007-10-25 2017-11-07 Valencell, Inc. Noninvasive physiological analysis using excitation-sensor modules and related devices and methods
US9044180B2 (en) 2007-10-25 2015-06-02 Valencell, Inc. Noninvasive physiological analysis using excitation-sensor modules and related devices and methods
US8655426B2 (en) 2008-04-25 2014-02-18 Denso Corporation Device for measuring concentration of constituent in blood and measuring method
US9289175B2 (en) 2009-02-25 2016-03-22 Valencell, Inc. Light-guiding devices and monitoring devices incorporating same
US8934952B2 (en) 2009-02-25 2015-01-13 Valencell, Inc. Wearable monitoring devices having sensors and light guides
US9750462B2 (en) 2009-02-25 2017-09-05 Valencell, Inc. Monitoring apparatus and methods for measuring physiological and/or environmental conditions
JP2017159052A (en) * 2009-02-25 2017-09-14 ヴァレンセル,インコーポレイテッド Attachable device
JP2012518515A (en) * 2009-02-25 2012-08-16 ヴァレンセル,インコーポレイテッド Light guide device and monitor device incorporating the same
US11589812B2 (en) 2009-02-25 2023-02-28 Valencell, Inc. Wearable devices for physiological monitoring
US11660006B2 (en) 2009-02-25 2023-05-30 Valencell, Inc. Wearable monitoring devices with passive and active filtering
US9314167B2 (en) 2009-02-25 2016-04-19 Valencell, Inc. Methods for generating data output containing physiological and motion-related information
US9301696B2 (en) 2009-02-25 2016-04-05 Valencell, Inc. Earbud covers
US8942776B2 (en) 2009-02-25 2015-01-27 Valencell, Inc. Physiological monitoring methods
US10842387B2 (en) 2009-02-25 2020-11-24 Valencell, Inc. Apparatus for assessing physiological conditions
US9289135B2 (en) 2009-02-25 2016-03-22 Valencell, Inc. Physiological monitoring methods and apparatus
US9131312B2 (en) 2009-02-25 2015-09-08 Valencell, Inc. Physiological monitoring methods
US10076282B2 (en) 2009-02-25 2018-09-18 Valencell, Inc. Wearable monitoring devices having sensors and light guides
US10092245B2 (en) 2009-02-25 2018-10-09 Valencell, Inc. Methods and apparatus for detecting motion noise and for removing motion noise from physiological signals
US8989830B2 (en) 2009-02-25 2015-03-24 Valencell, Inc. Wearable light-guiding devices for physiological monitoring
US9955919B2 (en) 2009-02-25 2018-05-01 Valencell, Inc. Light-guiding devices and monitoring devices incorporating same
US11471103B2 (en) 2009-02-25 2022-10-18 Valencell, Inc. Ear-worn devices for physiological monitoring
US10448840B2 (en) 2009-02-25 2019-10-22 Valencell, Inc. Apparatus for generating data output containing physiological and motion-related information
US8929966B2 (en) 2009-02-25 2015-01-06 Valencell, Inc. Physiological monitoring methods
US11160460B2 (en) 2009-02-25 2021-11-02 Valencell, Inc. Physiological monitoring methods
US10898083B2 (en) 2009-02-25 2021-01-26 Valencell, Inc. Wearable monitoring devices with passive and active filtering
US10542893B2 (en) 2009-02-25 2020-01-28 Valencell, Inc. Form-fitted monitoring apparatus for health and environmental monitoring
US8929965B2 (en) 2009-02-25 2015-01-06 Valencell, Inc. Light-guiding devices and monitoring devices incorporating same
US8923941B2 (en) 2009-02-25 2014-12-30 Valencell, Inc. Methods and apparatus for generating data output containing physiological and motion-related information
US11026588B2 (en) 2009-02-25 2021-06-08 Valencell, Inc. Methods and apparatus for detecting motion noise and for removing motion noise from physiological signals
US8886269B2 (en) 2009-02-25 2014-11-11 Valencell, Inc. Wearable light-guiding bands for physiological monitoring
US10716480B2 (en) 2009-02-25 2020-07-21 Valencell, Inc. Hearing aid earpiece covers
US10750954B2 (en) 2009-02-25 2020-08-25 Valencell, Inc. Wearable devices with flexible optical emitters and/or optical detectors
US8788002B2 (en) 2009-02-25 2014-07-22 Valencell, Inc. Light-guiding devices and monitoring devices incorporating same
US8700111B2 (en) 2009-02-25 2014-04-15 Valencell, Inc. Light-guiding devices and monitoring devices incorporating same
US10973415B2 (en) 2009-02-25 2021-04-13 Valencell, Inc. Form-fitted monitoring apparatus for health and environmental monitoring
US10842389B2 (en) 2009-02-25 2020-11-24 Valencell, Inc. Wearable audio devices
US10827979B2 (en) 2011-01-27 2020-11-10 Valencell, Inc. Wearable monitoring device
US11324445B2 (en) 2011-01-27 2022-05-10 Valencell, Inc. Headsets with angled sensor modules
US9788785B2 (en) 2011-07-25 2017-10-17 Valencell, Inc. Apparatus and methods for estimating time-state physiological parameters
US9427191B2 (en) 2011-07-25 2016-08-30 Valencell, Inc. Apparatus and methods for estimating time-state physiological parameters
US9521962B2 (en) 2011-07-25 2016-12-20 Valencell, Inc. Apparatus and methods for estimating time-state physiological parameters
US10512403B2 (en) 2011-08-02 2019-12-24 Valencell, Inc. Systems and methods for variable filter adjustment by heart rate metric feedback
US9801552B2 (en) 2011-08-02 2017-10-31 Valencell, Inc. Systems and methods for variable filter adjustment by heart rate metric feedback
US11375902B2 (en) 2011-08-02 2022-07-05 Valencell, Inc. Systems and methods for variable filter adjustment by heart rate metric feedback
US10856749B2 (en) 2013-01-28 2020-12-08 Valencell, Inc. Physiological monitoring devices having sensing elements decoupled from body motion
US12076126B2 (en) 2013-01-28 2024-09-03 Yukka Magic Llc Physiological monitoring devices having sensing elements decoupled from body motion
US11684278B2 (en) 2013-01-28 2023-06-27 Yukka Magic Llc Physiological monitoring devices having sensing elements decoupled from body motion
US10076253B2 (en) 2013-01-28 2018-09-18 Valencell, Inc. Physiological monitoring devices having sensing elements decoupled from body motion
US11266319B2 (en) 2013-01-28 2022-03-08 Valencell, Inc. Physiological monitoring devices having sensing elements decoupled from body motion
US9538921B2 (en) 2014-07-30 2017-01-10 Valencell, Inc. Physiological monitoring devices with adjustable signal analysis and interrogation power and monitoring methods using same
US11638561B2 (en) 2014-07-30 2023-05-02 Yukka Magic Llc Physiological monitoring devices with adjustable signal analysis and interrogation power and monitoring methods using same
US11185290B2 (en) 2014-07-30 2021-11-30 Valencell, Inc. Physiological monitoring devices and methods using optical sensors
US11179108B2 (en) 2014-07-30 2021-11-23 Valencell, Inc. Physiological monitoring devices and methods using optical sensors
US10893835B2 (en) 2014-07-30 2021-01-19 Valencell, Inc. Physiological monitoring devices with adjustable signal analysis and interrogation power and monitoring methods using same
US11412988B2 (en) 2014-07-30 2022-08-16 Valencell, Inc. Physiological monitoring devices and methods using optical sensors
US12274567B2 (en) 2014-07-30 2025-04-15 Yukka Magic Llc Physiological monitoring devices and methods using optical sensors
US12193845B2 (en) 2014-07-30 2025-01-14 Yukka Magic Llc Physiological monitoring devices and methods using optical sensors
US11638560B2 (en) 2014-07-30 2023-05-02 Yukka Magic Llc Physiological monitoring devices and methods using optical sensors
US11337655B2 (en) 2014-07-30 2022-05-24 Valencell, Inc. Physiological monitoring devices and methods using optical sensors
US11252498B2 (en) 2014-08-06 2022-02-15 Valencell, Inc. Optical physiological monitoring devices
US10015582B2 (en) 2014-08-06 2018-07-03 Valencell, Inc. Earbud monitoring devices
US11330361B2 (en) 2014-08-06 2022-05-10 Valencell, Inc. Hearing aid optical monitoring apparatus
US10536768B2 (en) 2014-08-06 2020-01-14 Valencell, Inc. Optical physiological sensor modules with reduced signal noise
US10623849B2 (en) 2014-08-06 2020-04-14 Valencell, Inc. Optical monitoring apparatus and methods
US11252499B2 (en) 2014-08-06 2022-02-15 Valencell, Inc. Optical physiological monitoring devices
US10779062B2 (en) 2014-09-27 2020-09-15 Valencell, Inc. Wearable biometric monitoring devices and methods for determining if wearable biometric monitoring devices are being worn
US9794653B2 (en) 2014-09-27 2017-10-17 Valencell, Inc. Methods and apparatus for improving signal quality in wearable biometric monitoring devices
US10798471B2 (en) 2014-09-27 2020-10-06 Valencell, Inc. Methods for improving signal quality in wearable biometric monitoring devices
US10834483B2 (en) 2014-09-27 2020-11-10 Valencell, Inc. Wearable biometric monitoring devices and methods for determining if wearable biometric monitoring devices are being worn
US10382839B2 (en) 2014-09-27 2019-08-13 Valencell, Inc. Methods for improving signal quality in wearable biometric monitoring devices
US10506310B2 (en) 2014-09-27 2019-12-10 Valencell, Inc. Wearable biometric monitoring devices and methods for determining signal quality in wearable biometric monitoring devices
CN107371361A (en) * 2015-03-23 2017-11-21 皇家飞利浦有限公司 Optical Vital Signs Sensor
WO2016150749A1 (en) 2015-03-23 2016-09-29 Koninklijke Philips N.V. Optical vital signs sensor
JP2018512187A (en) * 2015-03-23 2018-05-17 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. Optical vital sign sensor
US10610158B2 (en) 2015-10-23 2020-04-07 Valencell, Inc. Physiological monitoring devices and methods that identify subject activity type
US10945618B2 (en) 2015-10-23 2021-03-16 Valencell, Inc. Physiological monitoring devices and methods for noise reduction in physiological signals based on subject activity type
US12285244B2 (en) 2015-10-23 2025-04-29 Yukka Magic Llc Physiological monitoring devices and methods for noise reduction in physiological signals based on subject activity type
US10966662B2 (en) 2016-07-08 2021-04-06 Valencell, Inc. Motion-dependent averaging for physiological metric estimating systems and methods

Similar Documents

Publication Publication Date Title
JP2001025462A (en) Physiological signal detecting device
US20220225886A1 (en) Optical vital signs sensor
US6912413B2 (en) Pulse oximeter
US9649055B2 (en) System and methods for physiological monitoring
US9380969B2 (en) Systems and methods for varying a sampling rate of a signal
CN1100514C (en) Pulse oximeter sensor suitable for low saturation and method for measuring blood oxygen saturation
CN102238898B (en) Apparatus and method for recording vital parameter
US9480423B2 (en) Diagnostic measuring apparatus with integrated spectrometer
US20100331640A1 (en) Use of photodetector array to improve efficiency and accuracy of an optical medical sensor
US20130204102A1 (en) System and method for non-invasive determination of hemoglobin concentration in blood
WO2017202120A1 (en) Method and device for collecting ppg signal
US20090326347A1 (en) Synchronous Light Detection Utilizing CMOS/CCD Sensors For Oximetry Sensing
CN101564290A (en) Optical multi-parameter physiology monitoring instrument
US20230210390A1 (en) Sensor device to mitigate the effects of unwanted signals made in optical measurements of biological properties
US11543292B1 (en) Low-frequency noise cancellation in optical measurements
US20130030265A1 (en) Systems & method for determining blood component concentration
CN109998559B (en) A near-infrared brain oxygen detection system and method
JPH09262213A (en) Biological information detection device
McEwen et al. Noninvasive monitoring with strongly absorbed light
CN211299938U (en) Intelligent wearable device
CN117297541A (en) Method for detecting skin, PPG sensor and electronic device
CN203303060U (en) Wireless mini-type low-load blood oxygen pulse rate sensor for human body local area network
EP4142587A1 (en) System and method for interference and motion detection from dark periods
CN110621213B (en) Signal processing device for analyzing biosignal and biosignal analyzing device using same
EP4393385B1 (en) Photoelectric physiological signal acquiring and processing device

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040623

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040629

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20041102